Manuela Cipolletti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Activation of the envelope stress-responsive two-component system AmgRS compensates for depletion of the essential lipoprotein signal peptidase LspA in Pseudomonas aeruginosa.
Journal: Current research in microbial sciences
Published: February 16, 2026
Exploring novel biomarkers for endocrine disruptor exposure: insights into extra-nuclear signaling pathways of estrogen and androgen receptors.
Journal: Environmental toxicology and pharmacology
Published: October 30, 2025
The natural L370F ERα variant confers endocrine resistance and sensitivity to ATRA in metastatic breast cancer cells.
Journal: Cell communication and signaling : CCS
Published: June 26, 2025
Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167.
Journal: Cancers
Published: November 06, 2024
Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Journal: Scientific reports
Published: December 19, 2023
PMM2 controls ERα levels and cell proliferation in ESR1 Y537S variant expressing breast cancer cells.
Journal: Molecular and cellular endocrinology
Published: June 28, 2023
A Novel Resveratrol-Induced Pathway Increases Neuron-Derived Cell Resilience against Oxidative Stress.
Journal: International journal of molecular sciences
Published: January 27, 2023
A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma.
Journal: Frontiers in endocrinology
Published: December 21, 2022
The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells.
Journal: Molecular oncology
Published: February 22, 2022
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 05, 2022
The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells.
Journal: Toxics
Published: July 27, 2021
Neuroglobin: A New Possible Marker of Estrogen-Responsive Breast Cancer.
Journal: Cells
Published: July 02, 2021
Last Updated: 09/26/2026